Literature DB >> 2015010

Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.

H W Jones1, R Ireland, G Senaldi, F Wang, M Khamashta, A J Bellingham, K Veerapan, G R Hughes, D Vergani.   

Abstract

Systemic lupus erythematosus (SLE) is highly prevalent in Malaysia, which has a mixed population of Malays, Chinese, and Indians. A quantitative enzyme linked immunosorbent assay (ELISA) was used to determine anticardiolipin antibody (aCL) levels (total immunoglobulin, IgG, and IgM) in 200 patients with SLE (164 Chinese, 26 Malay, and 10 Indian) attending the University Hospital of Kuala Lumpur, Malaysia, and 103 matched controls. Only 33 (16.5%) of the patients had raised aCL levels; 26 had raised IgG aCL, five IgM aCL, and two both IgG and IgM aCL. There was a low prevalence of raised levels of aCL in the population studied, which was seen in conjunction with a rare occurrence of thrombosis. The classical association of high aCL levels with thrombocytopenia and recurrent abortions was noted, though not with cerebral disease. The low prevalence of aCL in this study population of mixed racial origin contrasts with findings in European patients with SLE and lends support to the influence of local factors, be they genetic or environmental, on the clinical manifestations of this disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015010      PMCID: PMC1004368          DOI: 10.1136/ard.50.3.173

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

Review 1.  Anti-phospholipid antibodies.

Authors:  E N Harris; A E Gharavi; G R Hughes
Journal:  Clin Rheum Dis       Date:  1985-12

Review 2.  Ageing and autoantibodies.

Authors:  Y Tomer; Y Shoenfeld
Journal:  Autoimmunity       Date:  1988       Impact factor: 2.815

3.  Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.

Authors:  O Meyer; J C Piette; P Bourgeois; P Fallas; O Bletry; P Jungers; M F Kahn; P Godeau; A Ryckewaert
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

4.  Systemic lupus erythematosus with membranous lupus nephropathy in Malaysian patients.

Authors:  F Wang; L M Looi
Journal:  Q J Med       Date:  1984

5.  Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test.

Authors:  E N Harris; J K Chan; R A Asherson; V R Aber; A E Gharavi; G R Hughes
Journal:  Arch Intern Med       Date:  1986-11

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

8.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

9.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

10.  Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia.

Authors:  A O Frank
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

View more
  2 in total

Review 1.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

2.  Systemic lupus erythematosus pregnancies: the Sarawak experience and review of lupus pregnancies in Asia.

Authors:  C L Teh; J S Wong; N K N Ngeh; W L H Loh
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.